Search
for
Sort by
Research 91–120 of 1000+
- Health and fertility in World Health Organization group 2 anovulatory women
- When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
- Preliminary report of intraovarian injections of autologous platelet-rich plasma (PRP) in extremely poor prognosis patients with only oocyte donation as alternative: a prospective cohort study
- Sperm aneuploidy in infertile male patients: a systematic review of the literature
- 9 Diagnosis and therapy of hyperandrogenism
- Endocrine and Reproductive Effects of Polycystic Ovarian Syndrome
- The Effect of Alfacalcidiol and Metformin on Phenotype Manifestations in Women with Polycystic Ovary Syndrome – a Preliminary Study
- Choice of treatment for women with polycystic ovary syndrome
- Clinical Effects of Glucagon-Like Peptide-1 Agonist Use for Weight Loss in Women With Polycystic Ovary Syndrome: A Scoping Review
- Diagnosis and Management of Infertility due to Anovulation
- Evaluation of patients with polycystic ovarian syndrome at a tertiary care center
- Workup and Management of Polycystic Ovary Syndrome
- Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
- Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome
- Indications for a brain‐hair follicle axis: inhibition of keratinocyte proliferation and up‐regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- Teriflunomide in multiple sclerosis: an update
- Family planning 2011: better use of existing methods, new strategies and more informed choices for female contraception
- Clinico-biochemical characteristics of 229 Portuguese infertile women with polycystic ovary syndrome: clinical relevance and relationship with fertility treatment results
- Role of Anti-Androgens in the Management of Polycystic Ovary Syndrome (PCOS)
- Role of Anti-Androgens in the Management of Polycystic Ovary Syndrome (PCOS)
- Abstracts from the 2024 WDS Forum - virtual option
- The Evaluation of the Role of Androgens in Hirsutism and the Use of a New Anti-androgen “Cyproterone Acetate” for Therapy
- Anthralin/dithranol in dermatology
- AB0442 Real-life experience with belimumab in systemic lupus erythematosus (SLE): control of disease activity and flares in a multicenter cohort
- AVALIAÇÃO DO USO DE TELAS DIGITAIS POR CRIANÇAS E ADOLESCENTES EM TEMPOS DE PANDEMIA
- The effect of laparoscopic ovarian drilling on the serum levels of AMH, FSH, LH and Testosterone hormones, in patients with PCOS
- Integrating systemic agents in clinic-based practice
- A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea
- Management of the Female With Non-classical Congenital Adrenal Hyperplasia (NCCAH): A Patient-Oriented Approach